Register
Login:
Share:
Email Facebook Twitter


EXCLUSIVE: David Lenigas answers investor questions in a detailed interview about UKOG, Doriemus, LGC Capital, AfriAg and Angus Energy.


Sareum Share Chat (SAR)



Share Price: 0.875Bid: 0.85Ask: 0.90Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.05Spread as %: 5.88%Open: 0.925High: 0.925Low: 0.875Yesterday’s Close: 0.875


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


minden
Posts: 1,740
Off Topic
Opinion:No Opinion
Price:0.875
Sar
Sun 12:07
has been treading water for a long time. It needs positive PR to drive this good company forward.
 
Krone
Posts: 173
Off Topic
Opinion:No Opinion
Price:0.875
RE: Lupus - THOTH2
Sun 10:40
No, but I have access to Open Athens so will get searching...
Thoth2
Posts: 1,647
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.875
RE: Lupus - THOTH2
Sun 00:20
If you are good at looking ? Have you found the tyk2vcancer results published but not on the website. ?
Krone
Posts: 173
Off Topic
Opinion:No Opinion
Price:0.875
RE: Lupus - THOTH2
Sat 21:48
Thank you, so to be clear, within 10 weeks we should know the lupus results?
Thoth2
Posts: 1,647
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.875
RE: Lupus - THOTH2
Sat 20:48
Candidate selection is not the same as reporting results. We have reported results in psoriasis. Rheumatoid arthritis and 2 types of cancer already without having selected a compound.
They are different activities.
Krone
Posts: 173
Off Topic
Opinion:No Opinion
Price:0.875
Lupus - THOTH2
Sat 11:33
You indicate below that the Lupus study reports this year....the RNS states '...Disease model studies with these compounds are planned during the fourth quarter of 2017. If these disease model studies are successful, the Company expects to move into the candidate selection phase in the first half of 2018'....
Can't see where it says SAR/SRI will be reporting this year? Can you clarify please. Thanks
lutonnews
Posts: 3,183
Off Topic
Opinion:No Opinion
Price:0.875
RE: A few pet peeves!
Sat 09:57
Some excellent points and in many instances similar to my own way of thinking.
Everyone has their own investment strategy . Imo when you invest in AIM and especially drug development stocks similar to SAR you should never put in more money than you can AFFORD to lose .
As Kovno states its long odds against one company making you a fortune but you have much more chance of earning a crust if you spread your risk across a spectrum of plays.
Currently I hold 3 AIM resource stocks along with a portfolio of 7 drug development plays . This p/f is weighted ( and heavily weighted on first 2 ) on how I perceive as risk v reward . Top weighted in volume in order going down as follows IMM , SAR , MTFM , SCLP , EVG , VRP and VAL .
The profit I have made top slicing here and in IMM so far has paid for the purchases in others.
Everyone who participates on these boards has a different agenda and perspective . For some its just like being in the bookies gambling their last few quid on an all or nothing situation and usually ending up with nothing , for those at the other end of the range who just play with a small percentage of their overall wealth looking for an opportunity to invest a little and make a profit at long odds.
Lucky enough to be one of the latter.
Best of luck to everyone in our shared objective of hoping to make money whatever our trading strategy is.
Been invested in AIM type stocks for over a decade and being honest have had a few right touches in recent years but overall regarding shares Ihave lost far more than I have made.
ATB and be lucky to all.
belhus
Posts: 335
Off Topic
Opinion:No Opinion
Price:0.875
View Thread (4)
sar
Sat 08:05
KOVNO I total agree with all you say but to me a major plus is that Stephen Parker came on board he has no reason to waste his time on a company like Sareum just look at his record bringing small companies through
Again I agree these guys who are constantly on posting silly little messages while allegedly travelling all around Europe need to calm down
Kovno
Posts: 61
Off Topic
Opinion:No Opinion
Price:0.875
View Thread (6)
A few pet peeves!
Sat 07:31
Feel free to add your own...

1. "I believe in the science" I find it weird that so many people assert this as some kind of sign that they know what they are doing. I have no doubt that the guys at SAR are competent scientists doing good work. This has very little bearing on whether the company will succeed. It will take excellent scientists to prove that the compounds don't work too!
2. Any predicitions for the price on a daily basis. It's almost completely random at such a small scale. And irrelevant anyway. I've been in this share over 5 years and am likely to be here a few more. Unless you are a trader looking for a quick 10% you really shouldn't care about such small movements.
3. Precise price predictions. Thoth2 is clearly a knowledgeable person and seems genuine, but I find the repetition of 28p quite disingenuous.. The calculations might be fair but there is such a large margin for error that it is misleading to repeat such a precise figure. Let's just say there is the potential for 20p-40p if certain criteria are met. No one can say any more than that.
4. "This is undervalued" The nature of these companies is surely that they are all or nothing. If the trials succeed and they manage to licence a drug or get one to market there are enormous profits to be had. If they fail they are worth virtually nothing. So the share price will reflect that. Is a one in ten chance of being a £1000m company worth £100m? Well, maybe, but remember there is a nine in ten chance that it will be worth nothing. If you are invested in ten similarly undervalued companies you can be fairly confident that you will do okay overall. But just one company is nothing more than a gamble. I'm happy to take this gamble with SAR but I realise that I am either likely to lose most of it or make a lot of money. It is not going to gradually rise and give me a nice steady income! As things stand a price of 2.5p is my first target. At that point I will be very tempted to take some profits. But of course if it gets there I will expect more!
5. Complaining about the PR. Only important if you are looking for spikes to play with. Otherwise just wait for the company to progress. I don't understand people complaining about the wording of RNSs. This can only affect the price on very short timescales. In the end it is irrelevant.

Sorry, just wanted to whinge a bit! I've been in this share for more than five years now and my average is about 1.05 so I haven't made much progress. I'm quite happy to continue holding, though. It's a punt, but one that seems to have a fair chance of making me quit e a bit of money, Good luck, everyone. Be patient!
Utahsaints
Posts: 966
Off Topic
Opinion:No Opinion
Price:0.875
RE: Strategy.............
Sat 07:08
Into 70 soon but up to 1p by Jan 2018




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.